Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial.

Carolyn S P Lam,Ileana L Piña,Yinggan Zheng,Diana Bonderman,Anne-Catherine Pouleur,Clara Saldarriaga,Burkert Pieske,Robert O Blaustein,Richard Nkulikiyinka,Cynthia M Westerhout,Paul W Armstrong

JACC. Heart failure（2023）

引用 1|浏览16

暂无评分

摘要

Although elderly women received less intense background HF therapy than men, their prognosis was nominally better. The benefit of vericiguat was independent of age and sex. (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction [HFrEF] [MK-1242-001] [VICTORIA]; NCT02861534).

查看译文

关键词

age,heart failure with reduced ejection fraction,sex,vericiguat

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要